Wed, Jul 30, 2014, 6:46 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Avanir Pharmaceuticals, Inc. Message Board

  • mikie_avnr24 mikie_avnr24 Mar 12, 2013 11:12 AM Flag

    Like i said,,same ole same ole till the generic lawsuit is over with...Shorts know how long they have...


    waiting game,,a EU approval will not let them go away even a deal with the up front payment..They think AVNR is going to zero!..The generic lawsuit is the cloud over this stock,ever since it was announced from say one she dropped like a rock in the water!

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Any contract to purchase by smart money would be made before then but contingent upon a successful patent litigation outcome and close afterward. JMHO

    • big cloudd over avnr- both dextromorphan and quinidine have been off patent and available gernerically for years for pennies. this company would disappear

    • why do u see the patent case as being something they can win? multiple layers of protection alone is a massive hurdle to overcome. There was then the FDA themselves essentially rejecting via the CRL the old formula. If that doesn't show how new and different N is in terms of being a new formula i don't know what does. Generics have at best...a less than 1% chance of winnng IMO and any short waiting on that is really not that bright.

      Sentiment: Strong Buy

5.40+0.06(+1.12%)Jul 30 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.